Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: Role of nuclear factor-κB, cyclooxygenase 2, and matrix metalloprotease 9

Cancer Research

Volumn 62, Issue 17, 2002, Pages 4945-4954

  Banerjee, Sanjeev ^a   Bueso Ramos, Carlos ^a   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CYCLOOXYGENASE 2; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHYTOALEXIN; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER INVASION; CANCER PREVENTION; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MITOSIS; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR VOLUME; WEIGHT GAIN; WESTERN BLOTTING;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADENOCARCINOMA; ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOGENS; CELL DIVISION; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MAMMARY NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASE 9; MEMBRANE PROTEINS; NF-KAPPA B; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036733776     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Cancer statistics. 1997
2. Clinical chemoprevention: Developing a cancer prevention strategy
3. Effect of dietary phytochemicals on cancer development
4. Progress in cancer chemoprevention: Development of diet-derived chemopreventive agents
5. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the "French paradox"?
6. Cancer chemopreventive activity of resveratrol
7. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
8. Inhibition of human LDL oxidation by resveratrol
9. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests
10. Wines and grape juices as modulators of platelet aggregation in healthy human subjects
11. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21 (CIP) expression
12. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumor model
13. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells
14. 2 phase transition
15. Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials
16. 2
17. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines
18. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells
19. Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells
20. The cancer chemopreventive agent resveratrol is incorporated into model membranes and inhibits protein kinase Cα activity
21. Resveratrol, a remarkable inhibitor of ribonucleotide reductase
22. Inhibition of aryl hydrocarbon-induced cytochrome P-450 IAI enzyme activity and CYPIA1 expression by resveratrol
23. Resveratrol inhibits transcription of CYPIA1 in vitro by preventing activation of the aryl hydrocarbon receptor
24. Suppression of nitric oxide synthase and the down-regulation of the activation of NF-κB in macrophages by resveratrol
25. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells
26. The NF-κB/Rel family of transcription factors in oncogenic transformation and apoptosis
27. Rel/NF-κB/IκB proteins and cancer
28. Effects of resveratrol on 12-O-tetradecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin
29. Expression of a constitutive NF-κB-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells
30. Liver regeneration. IV. Transcriptional control of liver regeneration
31. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation
32. Chemopreventive properties of transresveratrol are associated with inhibition of activation of the IκB kinase
33. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer
34. A rapid and sensitive method for the quantitation of micrograms of protein utilizing the principle of protein dye binding
35. Assay for redox-sensitive transcription factor
36. Activation of transcription factor NF-κB is suppressed by curcumin (difemloylmethane)
37. Silymarin suppresses TNF-induced activation of NF-κB, c-Jun N-terminal kinase, and apoptosis
38. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB
39. Sulindac inhibits activation of the NF-κB pathway
40. Perspectives on cancer chemoprevention research and drug development
41. Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: Effect on NF-κB, AP-1, JNK, MAPKK and apoptosis
42. Suppression of tumor necrosis factor-activated nuclear transcription factor-κB, activator protein-1, c-Jun N-terminal kinase, and apoptosis by β-lapachone
43. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor κB in cancer cells versus normal cells
44. Colorectal cancer chemoprevention: Biochemical targets and clinical development of promising agents
45. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol
46. Estrogens, BRCA1, and breast cancer
47. Inhibitory potential of pregnancy and lactation on mammary carcinogenesis induced by a food carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, in Sprague Dawley rats
48. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells
49. Effect of constant light on DMBA mammary tumorigenesis in rats
50. Genistein suppresses mammary cancer in rats
51. Neonatal genistein chemoprevents mammary cancer
52. Activation of NF-B/Rel occurs early during neoplastic transformation of mammary cells
53. Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NF-κB action
54. Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus
55. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular signal regulated protein kinases and p38 kinase
56. Inhibition of gastric cancer cell proliferation by resveratrol: Role of nitric oxide
57. Resveratrol inhibits the proliferation of normal human keratinocytes in vitro
58. Resveratrol induces prostate cancer cell entry, into S phase and inhibits DNA synthesis
59. 2 phases of the cell cycle in U937 cells
60. Resveratrol modulates arachidonic acid release, prostaglandin synthesis, and 3T6 fibroblast growth
61. Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells
62. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells
63. Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: Meta-analysis of quality-adjusted survival
64. Sex differences in lung CYPIA1 expression and DNA adduct levels among lung cancer patients
65. Lung carcinogenesis: Resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cells